Comprehensive biosimilar comparability assessment via intact and subunit RP-MS and IEX-UV-MS using the Xevo G3 QTof system

In this application note, Waters demonstrates the use of Xevo™ G3 QTof platform to perform a comparability analysis for infliximab innovator Remicade^® and three biosimilars (Inflectra^®, Avsola^®, and Renflexis^®).